All News
Filter News
Found 808,967 articles
-
Oxford Biomedica Solutions Publishes Peer-Reviewed Journal Article On Novel Dual-Plasmid System, Resulting In Significantly Increased AAV Vector Productivity And Percentage Of Full Capsids Packaged
6/8/2023
Oxford Biomedica Solutions LLC, offers The Full Solution™ suite of services, which includes end-to-end development and manufacturing capabilities for cell and gene therapy.
-
Abivax Releases the Results of its June 5, 2023 Ordinary and Extraordinary General Meeting
6/8/2023
Abivax SA (Euronext Paris: FR0012333284 - ABVX) held its ordinary and extraordinary general meeting of shareholders on June 5, 2023, which was chaired by Marc de Garidel, CEO of Abivax and interim Chairman of the Board of Directors.
-
Remote Patient Monitoring System Provider Finds Greater Success After Switching to Smart Meter’s Cellular-Enabled Devices
6/8/2023
Founded in 2019 to use technology to help improve patient care and outcomes, CCN Health, a remote patient monitoring (RPM) system provider, quickly began to struggle with customer service issues associated with the Bluetooth® devices it was using.
-
Telesis Bio to Present at Jefferies Healthcare Conference 2023
6/8/2023
Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder of Telesis Bio will present today at the 2023 Jefferies Healthcare Conference, Thursday, June 8, 2023, at 10:00 am Eastern time / 7:00 am Pacific Time.
-
Travere Therapeutics Announces Presentations of Abstracts at the 60th European Renal Association (ERA) Congress 2023
6/8/2023
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present nine abstracts, including the interim analysis from the ongoing Phase 3 PROTECT Study evaluating FILSPARI™ (sparsentan) versus an active comparator in IgA nephropathy (IgAN), at the 60th ERA Congress in Milan, Italy, June 15-18, 2023.
-
Justera Health Secures Two Retail Locations for Naturevan Stores
6/8/2023
Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the "Company") is pleased to announce that the Company has secured two new bricks and mortar retail locations in Vancouver.
-
In a late-stage study of non-ambulatory patients with DMD on background corticosteroids, pamrevlumab failed to meet the primary endpoint for upper limb performance.
-
Promosome filed lawsuits Tuesday against Moderna and Pfizer/BioNTech, alleging that the vaccine developers used patent-protected mRNA technology without a license.
-
The Federal Trade Commission’s lawsuit takes an unusual strategy, according to legal experts, raising concerns and uncertainties in the biopharma industry.
-
Biosimilars effectively lowered cancer therapy Herceptin prices and made trastuzumab more accessible to patients, finds a new study from the USC Schaeffer Center.
-
DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
6/7/2023
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced an agreement with a Blues plan in Hawaii.
-
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
6/7/2023
Baudax Bio, Inc. today announced additional results from its Phase 2 clinical trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery.
-
Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
6/7/2023
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the appointment of Bill Little as EVP of Corporate Development and Strategy and Andrew Taylor as CFO.
-
Investigating the placenta: Discovery from Stowers Scientists shows why this often-overlooked organ should be given more attention
6/7/2023
The placenta, critical for healthy embryo development, is a multi-purpose organ with a precise lifespan—the length of a pregnancy.
-
Capricor Therapeutics Announces Follow-up Type-B Clinical Meeting with the FDA for CAP-1002 for the Treatment of Duchenne Muscular Dystrophy
6/7/2023
Capricor Therapeutics today announced an upcoming Type-B clinical meeting with the U.S. Food and Drug Administration (FDA), planned in early Q3 2023.
-
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 in Women Diagnosed with Menopausal Hot Flashes
6/7/2023
Vistagen today announced that PH80, one of the Company’s five investigational neuroactive nasal sprays, demonstrated statistically significant efficacy versus placebo in an exploratory Phase 2A study for the acute treatment of hot flashes (vasomotor symptoms) in women diagnosed with menopausal hot flashes.
-
Cornell University Launches Flagship Biotech, Pharma Management Summit
6/7/2023
The Jeb E. Brooks School of Public Policy at Cornell University recently announced the launch of its new Biotech and Pharmaceutical Management Program aimed at preparing the next generation of leaders in the rapidly evolving biotechnology and pharmaceutical fields.
-
MEKanistic Therapeutics ™ announces the appointment of Dr. Patricia LoRusso to its Scientific Advisory Board
6/7/2023
MEKanistic Therapeutics Inc. announces the addition of Dr. Patricia LoRusso to its Scientific Advisory Board.
-
TriNetX Announces the Appointment of Dr. K. Arnold Chan as Senior Vice President, Real-World Evidence Consulting
6/7/2023
TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Dr. K. Arnold Chan joined the company as Senior Vice President, Real-World Evidence Consulting.
-
First Patients Treated in the US with the World's Smallest Heart Pump
6/7/2023
Magenta Medical , developer of the world's smallest heart pump, announced today the initiation of its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device.